瘤缺血因干扰素-γ类似于生理血管回归
Thomas Kammertoens1,2, Christian Friese1,2, Ainhoa Arina3
1Institute of Immunology, Charité Campus Buch, 13125 Berlin, Germany.
Nature
|April 27, 2017
概括
干扰素- (IFNγ) 通过向内皮细胞,导致血管缩和瘤回归,对瘤排斥至关重要. 这种机制对于消除已有的瘤至关重要,
科学领域:
- 免疫学
- 癌症生物学
- 血管生物学
背景情况:
- 干扰素- (IFNγ) 在抗瘤免疫力中起着至关重要的作用,但其特定的结构点和排斥已建立的瘤的机制尚不清楚.
- 虽然IFNγ可以直接抑制癌细胞的生长,但它对瘤层的作用对于有效的瘤排斥至关重要.
研究的目的:
- 确定IFNγ针对哪些瘤结构细胞进行瘤排斥.
- 阐明IFNγ通过向瘤中介排斥的机制.
主要方法:
- 在大,血管化的瘤中使用诱导IFNγ和IFNγ-GFP融合蛋白的小鼠模型.
- 使用仅在定义的细胞类型中表达IFNγ受体的小鼠来评估细胞特异性反应.
- 应用静脉显微镜以实时可视化IFNγ诱导的血管变化.
主要成果:
- 对于IFNγ诱导的瘤回归,内皮细胞对IFNγ的反应是必要的和足够的.
- IFNγ引发了瘤血管的回归,导致血液流动停止和瘤崩.
- 观察到与TNF诱导的出血性瘤缩相似的瘤缺血症.
结论:
- IFNγ主要通过向内皮细胞来排斥已建立的瘤,导致血管缩和瘤缺血.
- 了解这种IFNγ介导的血管向机制对于开发更有效的采用性T细胞疗法至关重要.
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


